According to a new study published in The BMJ, substituting high quality plant foods such as legumes, nuts, or soy for red meat might reduce the risk of coronary heart disease; substituting whole grains and dairy products for total red meat, and eggs for processed red meat, might also reduce this risk. Substantial evidence suggests that high consumption of red meat, especially processed red meat, such as bacon, … Continue reading Replacing Red Meat with Plant Foods Reduces Risk of Coronary Heart Disease

Dr. Anita Tilwari1, Sakshi Bharadwaj2,Megha Budholia3  Senior Scientist ,Madhya Pradesh Council of Science & Technology,Bhopal , M.P. Master’s in Microbiology , Department of Microbiology , Barkatullah University, Bhopal, M.P. 462016 Master’s in Microbiology , Department of Microbiology,Career College,Bhopal,M.P.   Abstract : Endophytic fungi have proven to be rich sources of novel bioactive compounds with therapeutic potentials. The endophytic fungus is having rich source of secondary metabolites … Continue reading “Evaluation of bioactive secondary metabolites of endophytic fungus isolated from Medicinal Plant Sarcaasoca”

Advanced Virology Lab” for testing of COVID-19 has established in The National Botanical Research Institute (NBRI), Lucknow. The facility has been developed based on the guidelines of the Indian Council Medical Research (ICMR), the World Health Organisation (WHO), and the Ministry of Health and Family Welfare. Bio Safety Level (BSL) 3 level facility According to ICMR guidelines, BSL2 level facility is recommended for COVID-19 but … Continue reading Bio Safety Level-3 Advanced Virology Lab for COVID 19-NBRI

केंद्रीय औषधीय एवं सगंध पौधा संस्थान (सीमैप) द्वारा विकसित हर्बल कॉस्मेटिक उत्पादों के व्यावसायिक उत्पादन के लिए एक निजी कंपनी के साथ करार किया गया है। इस समझौते के तहत सीमैप द्वारा विकसित किए गए हर्बल उत्पादों- रिलैक्सोमैप, पेनज़ा, पेनछू, फ्लोमॉप और एक्ने प्रिवेंटिव फेसवॉश बनाने की तकनीक विकसित की गई है। औषधीय तथा सगंध पौधों के क्षेत्र में शोध एवं विकास के लिए कार्यरत … Continue reading सीमैप के हर्बल कॉस्मेटिक्स का होगा मार्केट प्रोडक्शन

CSIR-Central Drug Research Institute(CDRI) Lucknow, has received permission for carrying out Phase III randomised, Double blind, Placebo controlled trial of efficacy, safety and tolerability of antiviral drug Umifenovir. The Phase III Clinical Trials will be carried out at King George’s Medical University (KGMU), Dr. Ram Manohar Lohia Institute of Medical Sciences (RMLIMS) and ERA’s Lucknow Medical College & Hospital, Lucknow. Umifenovir is mainly used for … Continue reading Umifenovir can be a safe, efficacious, affordable drug against COVID-19- CDRI, India